RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
2015-01-01 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling
2018-01-01 Sarina, B; Mariotti, J; Bramanti, S; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo Stella, C; Santoro, A; Castagna, L
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
2022-01-01 Giulia, Maggioni; Bersanelli, Matteo; Erica, Travaglino; Ana Alfonso Piérola, ; Annika, Kasprzak; Arnan Sangerman Montserrat, ; Elisabetta, Sauta; Claudia, Sala; Tommaso, Matteuzzi; Manja, Meggendorfer; Matteo, Gnocchi; Lin-Pierre, Zhao; Cristina Astrid Tentori, ; Kathrin, Nachtkamp; Daniele, Dall'Olio; Ettore, Mosca; Marta, Ubezio; Alessia, Campagna; Antonio, Russo; Giulia, Rivoli; Massimo, Bernardi; Lorenza, Borin; Maria Teresa Voso, ; Marta, Riva; Esther, Oliva; Matteo, Zampini; Elena, Riva; Elena, Saba; Saverio, D'Amico; Luca, Lanino; Benedetta, Tinterri; Francesca, Re; Marilena, Bicchieri; Laura, Giordano; Giovanni, Angelotti; Pierandrea, Morandini; Anne Sophie Kubasch, ; Francesco, Passamonti; Alessandro, Rambaldi; Victor, Savevski; Santoro, Armando; Arjan, A van de Loosdrecht; Alice, Brogi; Valeria, Santini; Shahram, Kordasti; Guillermo, Sanz; Francesc, Sole; Norbert, Gattermann; Wolfgang, Kern; Uwe, Platzbecker; Lionel, Ades; Pierre, Fenaux; Torsten, Haferlach; Gastone, Castellani; Ulrich, Germing; Maria, Diez-Campelo; DELLA PORTA, MATTEO GIOVANNI; Genomed4all, Consortium
A SUMMARY OF THE MILAN EXPERIENCE WITH MULTIMODALITY THERAPIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ATTEMPTS TO IMPROVE LONG-TERM OUTCOME
1995-01-01 Santoro, A; Parra, Hs; Bidoli, P; Angelidou, M; Cataldo, I; Salvini, P; Valagussa, P; Milani, F; Ravasi, G; Benadonna, G
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
1982-01-01 Valagussa, P; Santoro, A; Fossati Bellani, F; Franchi, F; Banfi, A; Bonadonna, G
ABVD chemotherapy in the treatment of Hodgkin's disease.
1982-01-01 Bonadonna, G; Santoro, A
ABVD in the treatment of Hodgkin's disease.
1992-01-01 Bonfante, V; Santoro, A; Viviani, S; Valagussa, P; Bonadonna, G
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer(ASCEND-1): update results from the multicenter, open-label, phase 1 trial.
2016-01-01 Kim, D W; Mehra, R; Tan, D S; Felip, E; Chow, L Q; Camidge, D R; Vansteenkiste, J; Sharma, S; de Pas, T; Riely, G J; Solomon, B J; Wolf, J; Thomas, M; Schuler, M; Liu, G; Santoro, A
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
2004-01-01 Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study | 1-gen-2015 | Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L | |
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling | 1-gen-2018 | Sarina, B; Mariotti, J; Bramanti, S; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo Stella, C; Santoro, A; Castagna, L | |
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study | 1-gen-2022 | Giulia, Maggioni; Bersanelli, Matteo; Erica, Travaglino; Ana Alfonso Piérola, ; Annika, Kasprzak; Arnan Sangerman Montserrat, ; Elisabetta, Sauta; Claudia, Sala; Tommaso, Matteuzzi; Manja, Meggendorfer; Matteo, Gnocchi; Lin-Pierre, Zhao; Cristina Astrid Tentori, ; Kathrin, Nachtkamp; Daniele, Dall'Olio; Ettore, Mosca; Marta, Ubezio; Alessia, Campagna; Antonio, Russo; Giulia, Rivoli; Massimo, Bernardi; Lorenza, Borin; Maria Teresa Voso, ; Marta, Riva; Esther, Oliva; Matteo, Zampini; Elena, Riva; Elena, Saba; Saverio, D'Amico; Luca, Lanino; Benedetta, Tinterri; Francesca, Re; Marilena, Bicchieri; Laura, Giordano; Giovanni, Angelotti; Pierandrea, Morandini; Anne Sophie Kubasch, ; Francesco, Passamonti; Alessandro, Rambaldi; Victor, Savevski; Santoro, Armando; Arjan, A van de Loosdrecht; Alice, Brogi; Valeria, Santini; Shahram, Kordasti; Guillermo, Sanz; Francesc, Sole; Norbert, Gattermann; Wolfgang, Kern; Uwe, Platzbecker; Lionel, Ades; Pierre, Fenaux; Torsten, Haferlach; Gastone, Castellani; Ulrich, Germing; Maria, Diez-Campelo; DELLA PORTA, MATTEO GIOVANNI; Genomed4all, Consortium | |
A SUMMARY OF THE MILAN EXPERIENCE WITH MULTIMODALITY THERAPIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ATTEMPTS TO IMPROVE LONG-TERM OUTCOME | 1-gen-1995 | Santoro, A; Parra, Hs; Bidoli, P; Angelidou, M; Cataldo, I; Salvini, P; Valagussa, P; Milani, F; Ravasi, G; Benadonna, G | |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. | 1-gen-1982 | Valagussa, P; Santoro, A; Fossati Bellani, F; Franchi, F; Banfi, A; Bonadonna, G | |
ABVD chemotherapy in the treatment of Hodgkin's disease. | 1-gen-1982 | Bonadonna, G; Santoro, A | |
ABVD in the treatment of Hodgkin's disease. | 1-gen-1992 | Bonfante, V; Santoro, A; Viviani, S; Valagussa, P; Bonadonna, G | |
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer(ASCEND-1): update results from the multicenter, open-label, phase 1 trial. | 1-gen-2016 | Kim, D W; Mehra, R; Tan, D S; Felip, E; Chow, L Q; Camidge, D R; Vansteenkiste, J; Sharma, S; de Pas, T; Riely, G J; Solomon, B J; Wolf, J; Thomas, M; Schuler, M; Liu, G; Santoro, A | |
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer | 1-gen-2004 | Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 827
- 1 Contributo su Rivista::1.1 Arti... 734
- 1 Contributo su Rivista::1.5 Abst... 84
- 1 Contributo su Rivista::1.2 Rece... 6
- 1 Contributo su Rivista::1.7 Lettera 3
Data di pubblicazione
- In corso di stampa 5
- 2020 - 2024 199
- 2010 - 2019 372
- 2000 - 2009 166
- 1990 - 1999 52
- 1982 - 1989 33
Rivista
- ANNALS OF ONCOLOGY 85
- JOURNAL OF CLINICAL ONCOLOGY 67
- BONE MARROW TRANSPLANTATION 31
- EUROPEAN JOURNAL OF CANCER 22
- BLOOD 19
- THE LANCET ONCOLOGY 19
- HAEMATOLOGICA 15
- LUNG CANCER 15
- CANCERS 14
- BRITISH JOURNAL OF CANCER 13
Keyword
- Humans 29
- Female 15
- Middle Aged 13
- Male 12
- Adult 10
- Aged 10
- COVID-19 10
- immunotherapy 10
- breast cancer 9
- Antineoplastic Agents 8
Lingua
- eng 489
- ita 2
Accesso al fulltext
- no fulltext 625
- reserved 189
- open 13